Sickle cell complications can affect virtually every organ system in the body — and some of them are medical emergencies. The most common and dangerous include vaso-occlusive pain crises, acute chest syndrome, stroke, splenic sequestration, and chronic kidney disease. About 90% of patients with sickle cell disease (SCD) will experience at least one significant complication by age 20, and these complications are the leading cause of early death in this population.
If you’re searching for information on sickle cell complications, you’re likely a patient, caregiver, or healthcare professional trying to understand what can go wrong — and what to do about it. This guide covers the eight most dangerous complications organ by organ, the warning signs you can’t afford to miss, and the specific tests used to monitor for each one.
Before organ damage becomes apparent, the body often sends earlier warnings, so recognising the everyday signs of sickle cell in adults helps you connect routine symptoms to the complications described below.
Quick Primer: Why Sickle Cells Cause So Much Damage
In sickle cell disease, a single point mutation in the HBB gene causes hemoglobin to polymerize when oxygen levels drop. This turns flexible, disc-shaped red blood cells into rigid, crescent-shaped cells that do two destructive things simultaneously:
- Vaso-occlusion: Sickled cells stick together and clog small blood vessels, cutting off oxygen to tissues downstream
- Chronic hemolysis: Sickled red blood cells live only 10–20 days (vs. 120 days for normal RBCs), causing relentless anemia and free hemoglobin release that damages blood vessel walls
This one-two punch — blocked vessels plus ongoing red cell destruction — explains why sickle cell complications span so many organs.
The 8 Most Dangerous Sickle Cell Complications by Organ
| Complication | Organ Affected | How Common | Emergency? |
|---|---|---|---|
| Vaso-occlusive crisis (pain crisis) | Bones, joints, abdomen | Most common complication overall | Sometimes |
| Acute chest syndrome (ACS) | Lungs | ~50% of SCD patients at least once | Yes |
| Stroke | Brain | 11% of HbSS patients by age 20 | Yes |
| Splenic sequestration | Spleen | Up to 30% of children with HbSS | Yes |
| Sickle cell nephropathy | Kidneys | ~30% develop CKD by age 40 | No (chronic) |
| Pulmonary hypertension | Heart/Lungs | 6–11% of adults with SCD | No (chronic) |
| Avascular necrosis (osteonecrosis) | Bones (hip, shoulder) | ~50% by age 35 (HbSS) | No (chronic) |
| Priapism | Genitourinary | Up to 42% of males with SCD | Yes (if >4 hours) |
1. Vaso-Occlusive Pain Crises
This is the hallmark of sickle cell disease and the number one reason SCD patients visit the emergency department. Pain can strike the long bones, spine, chest, or abdomen and ranges from moderate to excruciating. Some patients experience crises monthly; others go years between episodes.
Common triggers include dehydration, cold exposure, high altitude, infection, stress, and menstruation. Treatment involves aggressive IV hydration, opioid analgesia (typically morphine or hydromorphone), and treating any identified trigger.
2. Acute Chest Syndrome
ACS is the leading cause of death in adults with sickle cell disease. It presents with fever, chest pain, cough, and a new infiltrate on chest X-ray — essentially indistinguishable from pneumonia at first. The difference: it can deteriorate rapidly into respiratory failure.
Any SCD patient with chest pain and fever needs an urgent chest X-ray and arterial blood gas. Treatment includes exchange transfusion, antibiotics (covering atypical organisms), supplemental oxygen, and incentive spirometry.
3. Stroke
Children with HbSS face an 11% risk of overt stroke by age 20 — roughly 200–300 times higher than the general pediatric population. Silent cerebral infarcts are even more common, affecting 27–37% of children by age 14, and they cause cognitive decline even without obvious symptoms.
Transcranial Doppler (TCD) ultrasonography is the screening tool that changed everything. Annual TCD screening starting at age 2 identifies children with elevated cerebral blood flow velocities (>200 cm/sec), who can then be started on chronic transfusion therapy to reduce stroke risk by ~90%.
4. Splenic Sequestration
In young children with SCD, the spleen can suddenly trap massive amounts of blood, causing hemoglobin to drop 2+ g/dL below baseline within hours. The child develops a rapidly enlarging, painful spleen, pallor, and tachycardia. Without emergency transfusion, this is fatal.
Parents should be taught to palpate their child’s spleen and seek immediate medical attention if it enlarges suddenly.
5. Sickle Cell Nephropathy
The kidney’s medulla — with its low oxygen tension and high osmolarity — is uniquely vulnerable to sickling. Complications start early with loss of urine-concentrating ability (causing frequent urination and dehydration risk) and can progress to proteinuria, chronic kidney disease, and eventual renal failure. About 12% of HbSS patients develop end-stage renal disease.
6. Pulmonary Hypertension
Chronic hemolysis depletes nitric oxide and damages the pulmonary vasculature over time. An elevated tricuspid regurgitant jet velocity (≥2.5 m/sec) on echocardiography suggests pulmonary hypertension and is associated with a 2–10x increased mortality risk. All adults with SCD should undergo echocardiographic screening.
7. Avascular Necrosis
Repeated vaso-occlusion in the femoral or humeral head cuts off blood supply to the bone, causing it to collapse. This is excruciatingly painful and often requires joint replacement. It’s more common in HbSS and HbSβ⁰-thalassemia genotypes.
8. Priapism
A prolonged, painful erection lasting more than 4 hours is a urological emergency. It occurs in up to 42% of males with SCD, sometimes beginning in childhood. Delayed treatment can cause permanent erectile dysfunction.
Key Monitoring Tests Every SCD Patient Should Know About
- Complete blood count (CBC): Baseline hemoglobin in HbSS typically runs 6–9 g/dL — know your personal baseline
- Reticulocyte count: Elevated in chronic hemolysis; a sudden drop may signal aplastic crisis
- LDH, bilirubin, haptoglobin: Hemolysis markers tracked at routine visits
- Transcranial Doppler: Annual screening for stroke risk, ages 2–16
- Urine albumin-to-creatinine ratio: Annual screening for kidney involvement starting at age 10
- Echocardiogram: Screen for pulmonary hypertension in adults
- Ferritin: Monitors iron overload in patients on chronic transfusion therapy
When to Go to the Emergency Room
Not every pain crisis needs an ER visit, but the following situations are true emergencies:
- Fever ≥101.3°F (38.5°C) — SCD patients are functionally asplenic and at high risk for overwhelming sepsis
- Chest pain with shortness of breath or fever (possible acute chest syndrome)
- Sudden weakness, slurred speech, or facial drooping (stroke)
- Rapidly enlarging abdomen with pallor in a child (splenic sequestration)
- Priapism lasting more than 4 hours
- Pain crisis unresponsive to home medications
- Hemoglobin drop of more than 2 g/dL from baseline
Frequently Asked Questions
What is the most common sickle cell complication?
Vaso-occlusive pain crises are by far the most common complication. They account for over 90% of SCD-related hospital admissions. The severity and frequency vary widely — some patients are hospitalized multiple times a year, while others may go long stretches without a crisis.
What is the leading cause of death in sickle cell disease?
In children, infection (particularly pneumococcal sepsis) historically was the top killer — though pneumococcal vaccination and penicillin prophylaxis have dramatically reduced this. In adults, acute chest syndrome and pulmonary complications are the leading causes of death. Median life expectancy for HbSS patients in the U.S. is approximately 43–53 years, though this is steadily improving with newer therapies like hydroxyurea and gene therapy.
Can you prevent sickle cell complications?
Yes, many complications are preventable or reducible. Hydroxyurea increases fetal hemoglobin (HbF), which inhibits HbS polymerization and reduces pain crises by 44%, ACS episodes, and transfusion needs. Chronic transfusion therapy prevents primary and secondary stroke in children with abnormal TCDs. Newer therapies like voxelotor (increases hemoglobin oxygen affinity) and crizanlizumab (reduces vaso-occlusion) add more options. Gene therapy with exagamglogene autotemcel (Casgevy) now offers a potential cure.
Do all sickle cell genotypes have the same complications?
No. HbSS (sickle cell anemia) and HbSβ⁰-thalassemia generally cause the most severe complications. HbSC disease tends to be milder overall but carries a higher risk of retinopathy and avascular necrosis. HbSβ⁺-thalassemia is usually the mildest form. Genotype matters, but individual variation is significant — two patients with HbSS can have vastly different clinical courses.
Should I get my child tested for sickle cell disease?
In the United States, all 50 states include SCD in their newborn screening panel, so every baby born in a hospital is automatically tested. If you live outside the U.S. or have concerns about carrier status, hemoglobin electrophoresis is a simple blood test that can identify both sickle cell disease and sickle cell trait. Genetic counseling is recommended for couples who are both carriers (HbAS), as each pregnancy carries a 25% chance of producing a child with SCD.
